Cargando…
Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study
OBJECTIVE: To investigate the risk factors for the development of Pneumocystis jirovecii pneumonia (PCP) in patients with rheumatoid arthritis (RA) undergoing methotrexate (MTX) therapy. METHODS: This single-center retrospective cohort study included consecutive patients with RA who received MTX for...
Autores principales: | Ohmura, Shin-ichiro, Homma, Yoichiro, Masui, Takayuki, Miyamoto, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038457/ https://www.ncbi.nlm.nih.gov/pubmed/34511571 http://dx.doi.org/10.2169/internalmedicine.8205-21 |
Ejemplares similares
-
A Fatal Case of Concurrent Disseminated Tuberculosis, Pneumocystis Pneumonia, and Bacterial Septic Shock in a Patient with Rheumatoid Arthritis Receiving Methotrexate, Glucocorticoid, and Tocilizumab: An Autopsy Report
por: Ohmura, Shin-Ichiro, et al.
Publicado: (2021) -
Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept
por: Ospina, Fabio E., et al.
Publicado: (2014) -
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
por: Mori, Shunsuke, et al.
Publicado: (2015) -
Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis
por: Mori, Shunsuke, et al.
Publicado: (2012) -
Pneumocystis Jirovecii Pneumonia after Initiation of Tofacitinib Therapy in Rheumatoid Arthritis: Case-Based Review
por: Grigoropoulos, Ioannis, et al.
Publicado: (2019)